GENMAB US, INC.

EPKINLY

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

GENMAB US, INC.

Epkinly HCPCS:

J9321

HCPCS Code Descriptor:

Injection, epcoritamab-bysp, 0.16 mg

Category:

J Code

Epkinly NDCs:

82705-0010-01, 82705-0002-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Epkinly CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Epkinly:

EPKINLY is a Oncology drug manufactured by GENMAB US, INC. and administered via the Subcutaneous route of administration. The J Code: J9321 is aligned to the drug EPKINLY.

Epkinly is an injection prescribed to adults with certain types of diffuse large B-cell lymphoma, a type of non-Hodgkin lymphoma. This cancer is characterized by rapidly growing and spreading tumors in the lymph nodes, spleen, liver, bone marrow, or other tissues and organs. Epkinly works by directing the immune system to selectively target tumors, thus stopping and slowing their growth.

ACCESS PRICING AND MORE BY REGISTERING

J9321 Added Date:

January 1, 2024

J9321 Effective Date:

January 1, 2024

J9321 Termination Date:

HCPCS Active

Epkinly billing and coding information can be found through Genmab Us, Inc. at the link below:
Epkinly patient assistance information can be found through MyNavCare at the URL: https://www.mynavcare.com/
EPKINLY prescribing information can be found at the link below:
Information regarding EPKINLY’s side effects can be found at MedlinePlus